Develops in vivo genetic medicines with recombinases and nanoparticles.
| Title |
|---|
| Senior Scientist, NHP Study Lead / Analyst Full Time · $160K-$175K · 4+ YOE Cambridge, Massachusetts, United States · Onsite |
| Director / Senior Director, Computational & Protein Sciences Full Time · $250K-$290K · 10+ YOE Cambridge, Massachusetts, United States · Onsite |
| Senior Scientist, Upstream Process Development Full Time · $155K-$170K · 4+ YOE Cambridge, Massachusetts, United States · Onsite |
| Senior Research Associate, in vivo Pharmacology Full Time · 1+ YOE Cambridge, Massachusetts, United States · Onsite |
| Principal Scientist, Computational Biology Full Time · $180K-$195K · 5+ YOE Cambridge, Massachusetts, United States · Onsite |
| Activities | Genetic medicine developmentGenome engineeringTherapeutic protein engineeringDrug delivery developmentBiopharmaceutical research |
| Headquarters | US |
| Industries | BiotechnologyPharmaceuticals |
| Name | Stylus Medicine |
| Employees | 50 |
| Type | Private |
| Tagline | Develops in vivo genetic medicines with recombinases and nanoparticles. |
| Founded | 2,022 |
| Website | stylusmedicine.com |
| Latest Funding Round | Series A |
| Latest Funding Year | 2,025 |
| Latest Funding Amount | 85,000,000 |
| Latest Investors | RA Capital ManagementKhosla Ventures |